Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-13-001963
Filing Date
2013-10-09
Accepted
2013-10-09 16:25:34
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10-k.htm 10-K 1007707
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11422
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12031
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5571
5 GRAPHIC logo.jpg GRAPHIC 6541
  Complete submission text file 0001493152-13-001963.txt   3081724

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vnth-20130630.xml EX-101.INS 203076
7 XBRL SCHEMA FILE vnth-20130630.xsd EX-101.SCH 33443
8 XBRL CALCULATION FILE vnth-20130630_cal.xml EX-101.CAL 45846
9 XBRL DEFINITION FILE vnth-20130630_def.xml EX-101.DEF 69959
10 XBRL LABEL FILE vnth-20130630_lab.xml EX-101.LAB 209850
11 XBRL PRESENTATION FILE vnth-20130630_pre.xml EX-101.PRE 151392
Mailing Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064
Business Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-168930 | Film No.: 131143591
SIC: 2834 Pharmaceutical Preparations